VYNE MEXC RealStocks
Own real VYNE shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-19 05:51:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
VYNE Therapeutics Inc. (VYNE) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at --, with a market capitalization of -- and a P/E ratio of --. Over the past 52 weeks, its price has ranged from -- to --. This page covers its latest market performance, valuation, price trends and company information.
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
2026-03-31 |
VYNE Therapeutics Inc. (VYNE) last closed at $-- as of --, -- from the previous close of $--.
During the latest regular trading session, VYNE traded between $-- and $--, with a volume of -- shares. The closing price was -- and --.
Over the past seven days, VYNE Therapeutics Inc. (VYNE) moved from $38.00 to $28.56, representing a decline of 24.84% ($9.44).
The stock traded between $23.37 and $46.95 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 52.79 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary and differentiated therapies for the treatment of immuno-inflammatory conditions. The company is also in the pre-clinical stages of research, develop and commercialize products containing small molecule bromodomain and extra-terminal domain (BET) inhibitors for the treatment of any disease, disorder or condition in human. Its products include AMZEEQ, ZILXI, and FCD105.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 10 |
| Exchange | NASDAQ |
| Company Website |
View the latest dividend and stock split events for VYNE Therapeutics Inc.
Dividend | |
|---|---|
| Ex-Dividend Date | Jul 24, 2026 |
| Payment Date | Jul 23, 2026 |
| Dividend Per Share | $0.40242 |
Eligible investors can buy real shares of VYNE Therapeutics Inc. (VYNE) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to VYNE, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between VYNE shares and USD.
VYNE Shares to USD
1.00 VYNE shares = 0 USD
Calculations are estimates based on the latest available price and are for reference only.